Title
States Sub Department
Author
Issue Date
Applies To Year
Status
Cost
Ref No
BodyContent

Request

A

Could you tell me which department pays for prescriptions in Jersey?

B

How much has this department spent on prescriptions each year for the past 10 years?

C

Could you let me know how many prescriptions have been issued each year?

D

Could you also share top three drugs that cost the most for each year and what illness they treat?

Response

A

Prescriptions issued by community prescribers (general practitioners, dentists and approved non-medical nurse prescribers) are funded by the Health Insurance Fund, administered by the Social Security Department (soon to be Customer and Local Services Department).

B

Cost of prescriptions

​Year​Drug cost​Dispensing fee
​2008​£11,024,000​£4,355,000
​2009​£11,682,000​£4,803,000
​2010​£11,566,000​£5,137,000
​2011​£11,640,000​£5,362,000
​2012​£11,742,000​£5,656,000
​2013​£11,901,000​£6,220,000
​2014​£12,449,000​£6,413,000
​2015​£13,478,000 ​£6,688,000
​2016​£13,375,000​£6,815,000
​2017​£12,954,000 ​£6,874,000


C

Number of prescriptions

  • 2008 - 1,489,319

  • 2009 - 1,590,227

  • 2010 - 1,651,355

  • 2011 - 1,707,644

  • 2012 - 1,784,798

  • 2013 - 1,846,713

  • 2014 - 1,871,770

  • 2015 - 1,936,690

  • 2016 - 1,983,296

  • 2017 - 1,959,815

D

Data regarding the top three medicines ranked by cost is held going back to 2012. The department does not hold the information for earlier years.

2018 is shown as a partial year.

Calendar ​Year​Drug name​Total number of prescriptions dispensed ​Total net cost (£)​Main therapeutic use

​2018

(7 Months)

​Apixaban ​7,794 ​418,017.10 ​Oral anticoagulant that thins the blood and prevents strokes in, for example, people who have had heart valves replaced or who have an irregular heart rhythm called atrial fibrillation (AF)

​2018

(7 Months)

​Fluticasone Propionate (Inh)​8,883 ​372,328.28 ​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

​2018

(7 Months)

​Budesonide ​6,939​207,408.59​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

 

Calendar​ Year ​Drug name ​Total number of prescriptions dispensed ​Calendar Total net cost​Main therapeutic use
​2017​Fluticasone Propionate (Inh)​16,655 713,550.26​​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness
​2017​Pregabalin ​16,511 ​609,627.30​Treatment for epilepsy that is also used to manage chronic nerve pain
​2017​Budesonide  ​12,255 ​456,091.11​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

 

Calendar ​Year ​Drug name ​Total number of prescriptions dispensed ​Calendar Total net cost​Main therapeutic use
​2016​Pregabalin ​14,766 892,508.10 ​​Treatment for epilepsy that is also used to manage chronic nerve pain
​2016​Fluticasone Propionate (Inh)​17,665778,949.25 ​​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness
​2016​Budesonide  ​12,279​455,535.81​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

 

Calendar ​Year ​Drug name ​Total number of prescriptions dispensed ​Calendar Total net cost​Main therapeutic use
​2015​Pregabalin ​13,360 ​832,363.10  ​Treatment for epilepsy that is also used to manage chronic nerve pain
​2015​Fluticasone Propionate (Inh)​17,748​796,215.92 ​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness
​2015​Budesonide  ​12,432 ​468,495.14​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

 

Calendar ​Year ​Drug name ​Total number of prescriptions dispensed ​Calendar Total net cost​Main therapeutic use
​Fluticasone Propionate (Inh) ​17,865​816,600.28​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness
​Pregabalin  11,967 ​​757,164.60 ​Treatment for epilepsy that is also used to manage chronic nerve pain
​Budesonide    ​11,831​438,820.88​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

 

​Calendar Year ​Drug name ​Total number of prescriptions dispensed ​Calendar Total net cost​Main therapeutic use
​2013​Fluticasone Propionate (Inh) ​17,279​800,669.34​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness
​2013​Pregabalin  ​9,117 ​588,497.55​Treatment for epilepsy that is also used to manage chronic nerve pain
​2013​Budesonide   ​11,446​431,122.62​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness

 

Calendar ​Year ​Drug name ​Total number of prescriptions dispensed ​Calendar Total net cost​Main therapeutic use
​2012​Fluticasone Propionate (Inh)​16,234​773,848.29​Inhaled steroid that reduces inflammation in the airways. Used daily as a 'preventer' in asthma and chronic obstructive airways disease (COPD) to reduce breathlessness
​2012​Irbesartan   ​50,718​670,428.95​Blood pressure/heart failure
​2012​Atorvastatin  ​28,530​621,613.99 ​Cholesterol lowering

 

Document URL 1
Document URL 2
Document URL 3
Keywords
FOI Category
See Also
See Also 2
See Also 3
See Also 4
Approval Status Approved
Attachments
Content Type: GovJE FOI